Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective... by Maria Basagaña, Carlos Martínez-Rivera, Clara Padró, Ignasi Garcia-Olivé, Mimar Martínez-Colls, Juan Navarro, Laura Pardo, Paula Cruz, Gloria Cardona Peitx, Lídia Carabias, Albert Roger, Jorge Abad, Antoni Rosell

Get full text

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients by Cristina López, Cristina López, Nathalie Depreux, Isabel Bielsa, Albert Roger, Bibiana Quirant-Sanchez, Bibiana Quirant-Sanchez, Maria Basagaña, Yanina Jurgens, Clara Padró, Sira Miquel, Eva Martinez-Caceres, Eva Martinez-Caceres, Aina Teniente-Serra, Aina Teniente-Serra

Get full text